ArticleBreast cancer (Tokyo, Japan)2021

Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients.

Andrea Villasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.